Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy
- 1 November 2002
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 76 (1) , 37-45
- https://doi.org/10.1023/a:1020274709327
Abstract
The purpose of this retrospective study was to evaluate the influence of axillary disease on patients' survival after neoadjuvant chemotherapy and to assess patient and tumor characteristics...Keywords
This publication has 35 references indexed in Scilit:
- Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancerBritish Journal of Cancer, 2000
- Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-upAnnals of Oncology, 1999
- Primary Chemotherapy in Breast CancerAmerican Journal of Clinical Oncology, 1998
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancerAnnals of Oncology, 1994
- Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cmCancer, 1994
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- A HUMAN TUMOUR MODELThe Lancet, 1986
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983
- Management and survival of female breast cancer: Results of a national survey by the American college of surgeonsCancer, 1980